SCHEMBL24434964

SCHEMBL24434964

C/C=C/c1ccc(N=O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 5/20 0.46
▸ TSHR P16473 3/20 0.46
▸ TP53 P04637 3/20 0.46
▸ CYP3A4 P08684 3/20 0.46
▸ KDM4E B2RXH2 2/20 0.46
▸ LMNA P02545 2/20 0.46
▸ HSD17B10 Q99714 4/20 0.43
▸ MAPK1 P28482 2/20 0.43
▸ HIF1A Q16665 1/20 0.43
▸ CNR2 P34972 1/20 0.39
▸ TDP1 Q9NUW8 2/20 0.35
▸ HTT P42858 2/20 0.35
▸ ATM Q13315 1/20 0.35
▸ TYR P14679 1/20 0.34
▸ SMN1; SMN2 Q16637 3/20 0.33
▸ MAPT P10636 2/20 0.33
▸ NPSR1 Q6W5P4 2/20 0.33
▸ MEN1 O00255 1/20 0.33
▸ THRB P10828 1/20 0.33
▸ ALOX15 P16050 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12855366 1.00 ALDH1A1 (0.46) ALDH1A1TSHRTP53CYP3A4KDM4E
SCHEMBL28249128 0.80 ALDH1A1 (0.46) ALDH1A1TSHRTP53CYP3A4KDM4E
SCHEMBL13100599 0.79 NFE2L2 (0.52) ALDH1A1SMN1; SMN2MAPTKMT2ACA2
SCHEMBL9461723 0.79 CYP3A4 (0.65) ALDH1A1TSHRTP53CYP3A4KDM4E
SCHEMBL333123 0.79 CYP3A4 (0.65) ALDH1A1TSHRTP53CYP3A4KDM4E
SCHEMBL7527708 0.79 CYP3A4 (0.65) ALDH1A1TSHRTP53CYP3A4KDM4E
SCHEMBL13264504 0.76 ALDH1A1 (0.50) ALDH1A1TSHRCYP3A4LMNAHSD17B10
SCHEMBL28198316 0.76 ALDH1A1 (0.50) ALDH1A1TSHRCYP3A4LMNAHSD17B10
SCHEMBL27544851 0.76 CYP3A4 (0.62) ALDH1A1TSHRTP53CYP3A4KDM4E
SCHEMBL18657175 0.76 ALDH1A1 (0.39) ALDH1A1TSHRTP53CYP3A4KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220153732-A1 PROTEIN SECRETION INHIBITORS ENODIA THERAPEUTICS SAS (FR) 2022-05-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220153732-A1 PROTEIN SECRETION INHIBITORS SEC61B, SEC61A1, SEC61G ALDH1A1 4817/4885TSHR 2467/4885TP53 2849/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback